Changes in left ventricular geometry during antihypertensive treatment

被引:33
作者
Salvetti, Massimo
Paini, Anna
Bertacchini, Fabio
Stassaldi, Deborah
Aggiusti, Carlo
Rosei, Claudia Agabiti
Bassetti, Davide
Agabiti-Rosei, Enrico
Muiesan, Maria Lorenza [1 ]
机构
[1] Univ Brescia, Dept Clin & Expt Sci, Med ASST Spedali Civil Brescia 2, Brescia, Italy
关键词
Hypertension; Left ventricular hypertrophy; Regression; Echocardiography; Left ventricular mass (LVM); LV remodeling; Relative Wall thickness (RWT); Diuretics (D); Beta-blockers (BB); Calcium channel blockers (CCB); Angiotensin-converting enzyme inhibitors (ACE-I); Angiotensin receptor blockers (ARBS); CONVERTING ENZYME-INHIBITORS; AMBULATORY BLOOD-PRESSURE; CALCIUM-CHANNEL BLOCKER; RANDOMIZED DOUBLE-BLIND; II RECEPTOR BLOCKER; END-POINT REDUCTION; HYPERTENSIVE PATIENTS; CARDIAC-HYPERTROPHY; PROGNOSTIC IMPLICATIONS; LOSARTAN INTERVENTION;
D O I
10.1016/j.phrs.2018.06.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The reduction of echocardiographic left ventricular (LV) mass and the change toward a less concentric geometry during antihypertensive treatment are independently associated with a better prognosis. Blood pressure lowering treatment may reduce cardiac hypertrophy, although different effect on changes of LV mass have been reported among antihypertensive drug classes, while changes in echocardiographic evaluated LV geometry have not been systemically evaluated. It is not yet clear whether antihypertensive drugs may influence LV geometry. Our aim was to compare the effects of diuretics (D), beta-blockers (BB), calcium channel blockers (CCB), angiotensin-converting enzyme inhibitors (ACE-I), and angiotensin receptor blockers (ARBS) on relative wall thickness (RWT) in patients with hypertension on the basis of prospective, randomized comparative studies. Methods: MEDLINE, and the ISI Web of Sciences were searched for randomized clinical trials evaluating LV mass and geometry at baseline and end follow-up. We have performed a pooled pairwise comparisons of the effect of the 5 major drug classes on relative wall thickness changes, and of each drug class versus other classes statistically combined. Results: We selected 53 publications involving 7684 patients. A significant correlation was observed between percent changes from baseline to end of treatment in LV mass and those in systolic BP (r = 0.44, p < 0.001). Reduction of LV mass was significantly greater with CCB than with BB (P < 0.02) without other significant differences between drug classes. Percent changes in RWT were related to percent changes in LV mass/LVmass index (r = 0.68, p = 0.016) and of SBP (r = 0.64 p < 0.033). RWT decreased during treatment with all classes of drugs, except the combination of BB and D; the decrease of RWT was less with diuretics and sympatholytic drugs. Conclusions: In studies evaluating the effect of different classes of antihypertensive drugs on LV mass, the reduction of relative wall thickness seems to be less during treatment with diuretics.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 79 条
[1]   2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension [J].
Afridi, I ;
Canny, J ;
Yao, CH ;
Christensen, B ;
Cooper, RS ;
Kadiri, S ;
Hill, S ;
Kaplan, N ;
Kuschnir, E ;
Lexchin, J ;
Mendis, S ;
Poulter, N ;
Psaty, BM ;
Rahn, KH ;
Sheps, SG ;
Whitworth, J ;
Yach, D ;
Bengoa, R ;
Ramsay, L ;
Kaplan, N ;
Mendis, S ;
Poulter, N ;
Whitworth, J .
JOURNAL OF HYPERTENSION, 2003, 21 (11) :1983-1992
[2]   Cardiac structural and functional changes during long-term anti hypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA) [J].
Agabiti-Rosei, E ;
Trimarco, B ;
Muiesan, ML ;
Reid, J ;
Salvetti, A ;
Tang, R ;
Hennig, M ;
Baurecht, H ;
Parati, G ;
Mancia, G ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 2005, 23 (05) :1091-1098
[3]   ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study [J].
AgabitiRosei, E ;
Ambrosioni, E ;
DalPalu, C ;
Muiesan, ML ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 1995, 13 (11) :1325-1334
[4]   Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension [J].
Anan, F ;
Takahashi, N ;
Ooie, T ;
Yufu, K ;
Hara, M ;
Nakagawa, M ;
Yonemochi, H ;
Saikawa, T ;
Yoshimatsu, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (5-6) :353-359
[5]   Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension [J].
Ariff, Ben ;
Zambanini, Andrew ;
Vamadeva, Sarita ;
Barratt, Dean ;
Xu, Yun ;
Sever, Peter ;
Stanton, Alice ;
Hughes, Alun ;
Thom, Simon .
STROKE, 2006, 37 (09) :2381-2384
[6]   Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension [J].
Azizi, Michel ;
Perdrix, Ludivine ;
Bobrie, Guillaume ;
Frank, Michael ;
Chatellier, Gilles ;
Menard, Joel ;
Plouin, Pierre-Francois .
JOURNAL OF HYPERTENSION, 2014, 32 (10) :2038-2044
[7]   Long-Term Antihypertensive Treatment Fails to Improve E/e′ Despite Regression of Left Ventricular Mass An Anglo-Scandinavian Cardiac Outcomes Trial Substudy [J].
Barron, Anthony J. ;
Hughes, Alun D. ;
Sharp, Andrew ;
Baksi, Arun J. ;
Surendran, Praveen ;
Jabbour, Richard J. ;
Stanton, Alice ;
Poulter, Neil ;
Fitzgerald, Des ;
Sever, Peter ;
O'Brien, Eoin ;
Thom, Simon ;
Mayet, Jamil .
HYPERTENSION, 2014, 63 (02) :252-+
[8]  
Beltman Frank W., 1998, Blood Pressure, V7, P109
[9]   COMPARISON OF THE EFFECTS OF ISRADIPINE AND LISINOPRIL ON LEFT-VENTRICULAR STRUCTURE AND FUNCTION IN ESSENTIAL-HYPERTENSION [J].
BIELEN, EC ;
FAGARD, RH ;
LIJNEN, PJ ;
TJANDRAMAGA, TB ;
VERBESSELT, R ;
AMERY, AK .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (14) :1200-1206
[10]  
Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009